|
|
Georgia CTSA Weekly eRoundup February 11, 2022
|
|
|
Georgia CTSA Informatics Assistant Core Director Investigates Using AI to Improve Outcomes for Sepsis Patients
Rishikesan Kamaleswaran, PhD, Assistant Professor at Emory and Georgia CTSA Informatics Assistant Core Director, is leading a team of researchers to investigate the use of artificial intelligence to forecast therapeutic effectiveness and outcomes for patients with sepsis, a syndrome that claims 1 in 5 lives around the world. The team includes Informatics Co-Director Gari Clifford, DPhil, and Community Engagement Co-Investigator Omer T. Inan, PhD.
|
|
|
|
Healthcare Innovation Symposium: COVID Stress – The 2nd Pandemic
Join the Emory-Georgia Tech Healthcare Innovation Program and Georgia CTSA via Zoom on February 24 from 12:00-2:00 PM for the 36th Healthcare Innovation Symposium on ‘COVID Stress – The 2nd Pandemic: Problems and Potential Resources’. Keynote speaker Deb Houry, MD, MPH, CDC Acting Principal Deputy Director, and guest panelists will discuss several effective treatment modalities. This event is free and open to all faculty, staff, and students.
|
|
|
|
Georgia CTSA Southeast Regional Conference – Agenda & COVID-19 Safety Precautions
We look forward to hosting researchers across the region on March 3-4th at Callaway Resort & Gardens for what is sure to be two great days of science! View Agenda . Please know that the health and safety of all conference center guests and staff is our number one priority. To ensure everyone’s health and safety during the conference, please be aware that we will follow CDC recommended COVID-19 safety guidelines and take appropriate action. View the most up-to-date information online .
|
|
|
|
Funding (* New Opportunities)
|
|
|
NIH Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
|
|
|
|
* Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) – Due Dates Vary
FOA invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. Seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
|
|
|
|
* Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) – Due Dates Vary
FOA invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases.
|
|
|
|
Yerkes National Primate Research Center Pilot Research Program – Due February 25
Projects will be judged on potential to generate high-impact preliminary data that will result in peer-reviewed research project grants from outside sources and in peer-reviewed publications, and on how well they meet the five major review criteria: significance, approach, innovation, investigator and environment.
|
|
|
|
Emergency Awards: HEAL Initiative-Limited Competition: HEAL Initiative Resource Centers for the Pain Management Effectiveness Research Network (ERN) (U24 Clinical Trial Not Allowed) – LOI Due February 28
Solicits applications to continue support of Resource Center activities funded under RFA-TR-15-002 and RFA-TR-15-004; only applicants funded by RFA-TR-15-002 and RFA-TR-15-004 are eligible to apply for this FOA. Applications to this FOA will support Resource Centers for clinical trials funded through the HEAL Pain Management Effectiveness Research Network initiatives, including those funded under RFA-NS-19-021 and RFA-NS-20-028.
|
|
|
|
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) – LOI Due March 1
Funds meritorious applications that analyze existing data and resources from humans, including large, diverse national research cohorts, to answer specific questions about the development of human acute or chronic pain and its management. This FOA may be used to test hypotheses using existing data.
|
|
|
|
Ewing Marion Kauffman Foundation 2022 Knowledge Challenge – Due March 1
Supports activities that improve understanding of entrepreneurship and generate practical, actionable, and rigorous evidence to inform decision making and change systems. Focus areas: systems and structures to support inclusive prosperity and equitable opportunities and the future of work.
|
|
|
|
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) – LOI Due March 5
FOA invites eligible US small business concerns to submit STTR grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined health disparity population groups.
|
|
|
|
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) – LOI Due March 5
FOA invites eligible US small business concerns to submit SBIR grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined population groups who experience health disparities.
|
|
|
|
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Program – Internal Due March 15
The goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: research experiences, mentoring activities, curriculum or methods development.
|
|
|
|
Johnson & Johnson QuickFire Challenge: Improving Detection of Neurotoxicity in Immunotherapies – Due March 18
J&J is seeking methods and technologies aiming to optimize patient care for immunotherapies within the hematologic malignancy space by enabling the early detection of neurotoxic events. Of particular interest are technologies aiming to identify clinical manifestations to predict acute toxicities, including movement and neurocognitive disorders.
|
|
|
|
SOM I3 Nexus Research Awards – Due March 24
In partnership with the Georgia CTSA, the Emory SOM I3 (Imagine, Innovate, and Impact) Nexus Research Awards will provide seed money to fundamental biological and translational investigators for obtaining sufficient data to ultimately develop external collaborative funding applications, and to investigators who may not otherwise engage in multi- and interdisciplinary research. These awards require interdisciplinary team collaboration.
|
|
|
|
Georgia CTSA Biostatistics, Epidemiology and Research Design – Due March 31
Georgia CTSA’s Biostatistics, Epidemiology & Research Design (BERD) program is soliciting proposals to support novel methodological research in biostatistics, epidemiology, or health services research to advance clinical and translational research (CTR). Review criteria include quantitative methodological research to fill gaps in CTR, innovation, feasibility, and plans for dissemination and translation of results.
|
|
|
|
Pediatric Research Alliance Pilots Grants – LOI Due April 15
Children's and Emory offer pilot grants for faculty and centers in the Pediatric Research Alliance. These pilots are designed to stimulate new research projects, build new collaborations, and increase extramural funding for pediatric research. Proposals should be aimed towards generating preliminary data for subsequent extramural grant applications.
|
|
|
|
Georgia CTSA TL1 (T32-like) Training Grant Clinical and Translational Research Training – Postdoc Due March 15
The Georgia CTSA, the NIH-supported Clinical and Translational Science Award TL1 program) is focused on providing innovative didactic and mentored research training to individuals interested in careers that encompass clinical and/or translational research. The TL1 program provides an opportunity to complete the Master of Science in Clinical Research or the Certificate Program in Translational Research. The TL1 program supports predoctoral and postdoctoral trainees (medical and PhD students, resident and fellow physicians, PhD postdocs, and residents). A TL1 Grant Writing Application Workshop was held on December 3. The recorded workshop is on the TL1 webpage and at this link .
|
|
|
|
Emory Underrepresented Researchers in Medicine in the Areas of Vascular Factors, Alzheimer's Disease and Related Disorders – Due March 4
The Research Education Component of the Goizueta ADRC in collaboration with the DOM Diversity, Equity, & Inclusion Council is issuing a special RFA from trainees and junior faculty from backgrounds traditionally underrepresented in medicine, who are interested in developing greater experience in Alzheimer’s disease and related dementia research. Applicants who are interested in exploring the link between vascular factors and AD/ADRD are encouraged to apply.
|
|
|
|
Certificate Program in Translational Research (CPTR) – Apply by April 29
The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. The CPTR enhances and transforms translational research training for predoctoral PhD students, postdoctoral fellows (PhD or MD) and junior faculty at Emory University, Morehouse School of Medicine, Georgia Institute of Technology, and the University of Georgia.
|
|
|
|
Georgia CTSA Match
Looking to connect with experts in your field? Join the new Georgia CTSA Match! The platform encourages meaningful networking and collaboration by pairing researchers based on similar interests. These matches will help you to build networking opportunities acting as a catalyst to spur your research forward. Discover more and Join Now!
|
|
|
|
HPLC Bioanalytical Core
Emory HPLC Bioanalytical Core brings powerful platforms in support of investigators. The Core can identify and quantify monoamine neurotransmitters, amino acids, purine bases, and nucleotides from a variety of biological samples. We also provide tailored HPLC service in a broad range of research projects including neuroscience research, cancer research, drug development and clinical trial studies.
|
|
|
|
Bench2Market Talk – February 16
Join us via Zoom at 1:00 PM – 2:00 PM for The Reimbursement Riddle: How to transform a device into dollars. Learn about establishing a viable business model through reimbursement. Topics will include insurance coverage rules, coding, and payment using the Medicare program as a model.
|
|
|
|
Translational Science 2022 – Chicago – April 20-22
The Association for Clinical and Translational welcomes trainees, educators, researchers, physician scientists, and other health professionals engaged in clinical and translational science. Georgia CTSA Community Engagement Director, Dr. Tabia Akintobi, will be on a leadership panel on April 21 from 4:00 PM-5:00 PM to discuss the state of community engaged clinical research.
|
|
|
|
NIH Technology Accelerator Challenge for Maternal Health – Due April 22
The National Institute of Biomedical Imaging and Biomedical Engineering is launching the NIH Technology Accelerator Challenge for Maternal Health. Up to $1 million in cash prizes to spur and reward the development of low-cost, point-of-care molecular, cellular, and/or metabolic sensing and diagnostic technologies to guide rapid clinical decision-making, improve patient outcomes, and ultimately prevent maternal morbidity and mortality.
|
|
|
|
Join the All of Us Research Program
The All of Us Research Program from the National Institutes of Health is seeking one million or more people from across the U.S. By doing so, it hopes to one day help speed up medical research. People who join will share information about their health, habits, and what it’s like where they live. By looking for patterns, researchers may learn more about what affects people’s health.
|
|
|
|
COVID Force Seminar – February 11
Join us via Zoom at 12:00 PM to learn more about “Cardiac MRI Findings in MIS-C" with Matthew Dove, MD, “Long-term Outcomes in MIS-C” with Joshua Kaltman and “Comparison of MIS-C Related Myocarditis, Classic Viral Myocarditis, and COVID-19 Vaccine Related Myocarditis” with Trisha Patel, MD.
|
|
|
|
K-Club – February 14
Early career investigators, please join us via Zoom at 12:00 PM – 1:00 PM to learn more from NIH Program Director Sergey Radaev, PhD about options, interactions with NIH staff, and tips for submitting a strong application. This is an outstanding opportunity to hear directly from an NIH program officer with a demonstrated commitment to researcher career development.
|
|
|
|
AiR – February 15
Join us via Zoom at 12:30 PM to learn more about “Novel Hydrogel-Based Microvasculature-On-Chips for Studying Microvascular Dysfunction and Vaso-Occlusion in Sickle Cell Disease” with Yongzhi Qiu, PhD, and “Scalable Systematic Standardization of Transduction Enables Precision Gene Transfer for Personalized Cell Manufacturing” with Reginald Tran, PhD.
|
|
|
|
Health Services Research Seminar Series – February 23
Join us via Zoom at 2:00 PM to learn more about “90-day Outcomes after Peripheral Artery Disease Interventions” with Assistant Professor Olamide Alabi, MD.
|
|
|
|
Healthcare Innovation Symposium – February 24
Join us via Zoom from 12:00 PM - 2:00 PM to learn more about “COVID Stress – The 2nd Pandemic: Problems and Potential Resources.” The keynote speaker will be Deb Houry MD, MPH , Acting Principal Deputy Director of the CDC, and will include discussion of several effective treatment modalities. This event is free and open to all faculty, staff and students.
|
|
|
|
Neuroscience Research Networking Session – February 24
Join us via Zoom from 4:00-5:00 PM to meet potential new collaborators to brainstorm ideas for Pediatric Research Alliance pilot grant submissions. Learn more about the pilot opportunity here. We will plan networking around outcomes research, clinical research, and device development. Register by February 17.
|
|
|
|
AI Technologies to Support Individuals Experiencing Cognitive Decline – February 25
Join us in-person for an interactive workshop! The AI-CARING Institute aims to develop novel artificial intelligence systems to support long term care for individuals experiencing cognitive decline and their care networks. The goal of the workshop is to bring together clinical service providers and computing researchers to identify opportunities for developing technologies that identify changing needs and abilities, promote independence through support for daily activities, and assist in planning and coordination of care.
|
|
|
|
Rare Disease Day at NIH – February 28
Join us via Zoom 10:00 AM – 6:00 PM! The goal of this day is to raise awareness and generate positive action for the rare disease community. This year’s theme for Rare Disease Day is “Sharing Your Colors,” highlighting the various different types of rare diseases in the world!
|
|
|
|
CTSA Visiting Scholar Grand Rounds Lecture – February 28
Join us via Zoom at 12:00 PM to learn more about “Parent and Provider Perspectives on Childhood Vaccine Hesitancy” with Duke Assistant Professor Lavanya Vasudevan, PhD, MPH, CPH. The CTSA Visiting Scholar program consists of the CTSA Grand Rounds lecture and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers.
|
|
|
|
SCORE RIP Meeting – March 2
Join us via Zoom at 12:00 PM to learn more about “Ischemia with No Obstructive Coronary Artery Disease” with Associate Professor Puja K, Mehta, MD, FACC, FAHA and “Renal NMDA Receptors and Hypertension: Sex Differences” with Assistant Professor Cesar Romero MD, PhD.
|
|
|
|
Southeast Regional Clinical & Translational Science Conference – March 3-4
Join us at Callaway Resort and Gardens as we bring together researchers from across the region to present the best new health-related preclinical, clinical, implementation, and population- based research and build collaborative relationships. Keynote Speaker for this year’s conference is Joni L. Rutter, PhD, acting director of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). Learn more .
|
|
|
|
8th Annual Health Services Research Day – May 4
Join Georgia CTSA colleagues at Emory University SOM on May 4 for this symposium and networking opportunity where researchers across Georgia will learn about ongoing quality, effectiveness, and value-based research activities. Oral and poster presentations will be selected from submitted abstracts. Submit Abstracts by March 7.
|
|
|
|
Annual Southeastern Pediatric Research Conference – June 3
Join us in-person at the Georgia Aquarium or virtually for the 11th annual conference. The conference will highlight the scope of pediatric research conducted across the US southeast, with emphasis on research from Emory, Children’s Healthcare of Atlanta, Georgia Tech, and Morehouse School of Medicine. This year’s conference theme is "Development and Disease: Translating Insights from Genes and Environment to Transform Outcomes." Submit Abstract by April 1.
|
|
|
|
|